Is BPC 157 Banned? Oral vs. Injectable Forms Explained Pharmacological therapy remains central in ASCVD management. Statinsalong with ezetimibe, bempedoic acid and PCSK9 inhibitorscontinue to drive effective LDL cholesterol reduction and cardiovascular risk prevention. Growing focus is now on residual BPC 157 (5 mg) 98 + Shipping customsupplements Modulatory effects of BPC 157 on vasomotor tone and the activation of Src Caveolin 1 endothelial nitric oxide synthase pathway Scientific Reports TLDR; no. BPC 157 is a peptide that is not approved by the FDA, but it seems like our good friends over at the supplement industry marketing team have gotten their hands on